Α-Pyrrolidinobutiophenone

α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s^[2] which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.

α-Pyrrolidinobutiophenone

Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class B US: Schedule I[1]
Identifiers
IUPAC name (RS)-1-Phenyl-2-(1-pyrrolidinyl)-1-butanone
CAS Number	13415-82-2 Y HCl: 13415-54-8 Y
PubChem CID	23199082
ChemSpider	16251917 N
UNII	Y4B3AXV4I4 HCl: TVZ2316JM4 Y
CompTox Dashboard (EPA)	DTXSID201016919 DTXSID40631251, DTXSID201016919
Chemical and physical data
Formula	C14H19NO
Molar mass	217.312 g·mol−1
3D model (JSmol)	Interactive image
SMILES C2CCCN2C(CC)C(=O)c1ccccc1
InChI InChI=1S/C14H19NO/c1-2-13(15-10-6-7-11-15)14(16)12-8-4-3-5-9-12/h3-5,8-9,13H,2,6-7,10-11H2,1H3 N Key:GSESDIFGJCCBHN-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Legality

In the United States, it is a Schedule I controlled substance.^[3]

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.^[4]

As of October 2015 α-PBP is a controlled substance in China.^[5]

See also

• α-Pyrrolidinopropiophenone (α-PPP)
• α-Pyrrolidinopentiophenone (α-PVP)
• α-Pyrrolidinopentiothiophenone (α-PVT)
• α-Pyrrolidinohexiophenone (α-PHP)
• 4'-Methyl-α-pyrrolidinobutiophenone (MPBP)
• 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP)
• Buphedrone